Skip to content

Author

Y. Abdou

We have 2 of 111 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Nov 2026

Evolving First-Line Treatment Strategies in ERBB2-Positive Metastatic Breast Cancer: A Review.

Importance The treatment landscape of ERBB2 (formerly HER2)-positive metastatic breast cancer has evolved substantially during the past decade, with emerging therapies challenging the long-standing induction-maintenance paradigm established by the CLEOPATRA trial (NCT00567190). However, optimal treatment selection, seq...

Yu Zong, L. Carey, Y. Abdou · 0 citations
Open access Oct 2026

Integrating ctDNA-based ESR1m monitoring into first-line care for ER+, HER2− advanced breast cancer: a consensus workflow

Practical, experience-informed considerations are supplemented by an opinion-based consensus workflow model designed to provide clinicians with a flexible framework for implementing ctDNA-based ESR1m monitoring during first-line care for ER+, HER2– aBC.

Y. Abdou, Amber Cipriani, Trevor Feinstein et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.